SC
PFE icon

SummitTX Capital’s Pfizer PFE Stock Holding History

SummitTX Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.49M Buy
103,387
+74,665
+260% +$1.95M 0.06% 311
2026
Q1 		$807K Buy
+28,722
New +$765K 0.03% 489
2025
Q4 		– Sell
-71,580
Closed -$1.82M – 908
2025
Q3 		$1.82M Sell
71,580
-366,698
-84% -$9.05M 0.08% 275
2025
Q2 		$10.6M Buy
438,278
+277,444
+173% +$6.47M 0.46% 41
2025
Q1 		$4.08M Buy
+160,834
New +$4.21M 0.18% 141

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SummitTX Capital's PFE Position: Q2 2026 in Review

SummitTX Capital increased its Pfizer (PFE) stake by 260% in Q2 2026, buying an estimated $1.95M and bringing the position to 103,387 shares worth $2.49M. The position accounts for 0.06% of the portfolio, ranked #311.

SummitTX Capital first reported a position in PFE in Q1 2025 and has held it in 5 quarters since. The position peaked at $10.6M in Q2 2025. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • SummitTX Capital held 103,387 shares of Pfizer worth $2.49M as of Q2 2026.
  • SummitTX Capital bought 74,665 Pfizer shares in Q2 2026, an estimated $1.95M.
  • Pfizer made up 0.06% of SummitTX Capital's portfolio in Q2 2026, its #311 holding.
  • SummitTX Capital first reported a position in Pfizer in Q1 2025 and has held it in 5 quarters since.
  • SummitTX Capital's Pfizer position peaked at $10.6M in Q2 2025.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.